Pharmacodynamics and epigenomics in clinical trials of epigenetic therapies.

被引:0
|
作者
Brown, R [1 ]
机构
[1] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:6275S / 6275S
页数:1
相关论文
共 50 条
  • [1] Designing and funding clinical trials of novel therapies.
    Antman, K
    Lagakos, S
    Drazen, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10): : 762 - 763
  • [2] Pharmacodynamics: biological activity of targeted therapies in clinical trials
    F. Rojo
    A. Dalmases
    J. M. Corominas
    J. Albanell
    Clinical and Translational Oncology, 2007, 9 : 634 - 644
  • [3] Pharmacodynamics: biological activity of targeted therapies in clinical trials
    Rojo, F.
    Dalmases, A.
    Corominasa, J. M.
    Albanell, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (10): : 634 - 644
  • [4] Randomized controlled trials of innovative therapies. Are they ethical?
    Truog, RD
    JOURNAL OF NEPHROLOGY, 1995, 8 (06) : 285 - 286
  • [5] Adaptive designs and adaptive learning for biomarker-based clinical trials for targeted therapies.
    Lee, J. Jack
    CLINICAL CANCER RESEARCH, 2014, 20
  • [6] Representation of women in clinical trials supporting the FDA-approval of contemporary anticancer therapies.
    Babcook, Melissa A.
    Nidhi, Neha
    Carter, Rebecca R.
    Bonsu, Janice
    Yildiz, Vedat
    Wei, Lai
    Ruz, Patrick
    Paskett, Electra D.
    Addison, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Clinical epigenomics for cardiovascular disease: Diagnostics and therapies
    Fischer, Matthew A.
    Vondriska, Thomas M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 154 : 97 - 105
  • [8] Clinical trials of WT1 peptide vaccine to gynecologic malignancies that are resistant to conventional therapies.
    Miyatake, T.
    Enomoto, T.
    Oka, Y.
    Nishida, S.
    Tsuboi, A.
    Shirakata, T.
    Morita, S.
    Sakamoto, J.
    Sugiyama, H.
    Kimura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Clinical pharmacology of inflammatory bowel disease therapies.
    Sandborn W.J.
    Faubion W.A.
    Current Gastroenterology Reports, 2000, 2 (6) : 440 - 445
  • [10] Epigenomics and epigenetic therapy
    Jones, Peter A.
    CELLULAR ONCOLOGY, 2008, 30 (03) : 225 - 225